Registration Opens for Questex’s LDI 2026, Featuring Early Access to In-Depth LDInstitute™Training

Professionals across live events, entertainment technology, and production can now register for LDI 2026, for the first time, secure seats in sought-after LDInstitute™ courses nearly two months earlier than ever before

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Registration is now open for Live Design International (LDI) 2026, Questex’s must-attend annual event for global entertainment design and technology professionals. Taking place December 2-8, 2026, at the Las Vegas Convention Center, LDI will once again bring together the designers, programmers, engineers, technicians, production teams, manufacturers, and innovators shaping the future of live experiences.

This year’s event is already gearing up to be one of the most exciting in LDI’s history, with expanded professional development opportunities, hundreds of exhibitors, cutting-edge technology demonstrations, immersive experiences, and the industry’s most comprehensive education program.

Early Access to LDInstitute™—A First for LDI

For the first time, attendees can also register early for the highly anticipated LDInstitute™ professional training courses. Many Institute courses feature limited hands-on enrollment and routinely sell out, making early registration the best way to guarantee access to these sought-after training opportunities.

With more than 75 expert-led training courses, many featuring limited hands-on enrollment that sells out each year, early registration gives attendees the best opportunity to secure a seat in some of the industry’s most in-demand technical training.

“LDI is where the live events industry comes together to discover new technology, sharpen skills, and build the relationships that move careers—and our industry—forward,” said Marian Sandberg, Vice President and Brand Leader, LDI. “We’re excited to open registration for LDI 2026 and give attendees early access to our Institute courses. These small-group training experiences provide unparalleled hands-on learning and consistently fill quickly, so we encourage attendees to secure their seats early.”

Register for Industry-Leading LDInstitute™ Training

LDInstitute delivers intensive, hands-on education taught by respected industry professionals across lighting, networking, production technology, media servers, design, and live event systems.

Sessions include:

  • grandMA3 Beginner and grandMA3 Special Topics
  • ETC Eos and High End console Training
  • Setting Up, Testing, and Troubleshooting Lighting Control Systems and Networks
  • Vectorworks Training
  • Green Hippo and Pixera media server Training
  • Ethernet For Entertainment
  • Cutting-edge AI Training
  • Additional technical and professional development courses

The LDInnovation™ Conference Returns

The full LDInnovation™ Conference agenda and speaker lineup will be announced in August, featuring industry leaders, innovators, and practitioners exploring the trends, technologies, and creative ideas shaping the future of live events and entertainment production.

Register Early & Save: Super Early Bird Rates Through August 14

Attendees who register now can take advantage of Super Early Bird pricing through August 14, 2026, and secure the lowest available rates for LDI 2026 and reduced rates for LDInstitute Courses.

LDI 2026 will feature:

  • Hundreds of exhibitors showcasing the latest in lighting, audio, video, projection, staging, automation, rigging, and immersive technologies
  • The LDInnovation™ Conference
  • 75+ LDInstitute™ training courses
  • Live demonstrations
  • Networking events
  • Career development opportunities
  • Experiences celebrating the creativity and technology behind live entertainment

To register to attend LDI, click here. To view LDInstitute Courses, click here.

For sponsorship opportunities, contact Kelly Turner.

Follow LDI on Instagram, LinkedIn, Facebook, X, YouTube and TikTok.

About Live Design International (LDI)
Established in 1988, Live Design International (LDI) is built on a 36-year history as the essential trade show and conference for global live design professionals. Attendees come to LDI to see the latest gear and entertainment technology in action, covering audio, lighting, projection, video, staging, special effects, and XR. It is also a great opportunity to refresh knowledge and professional training, in addition to networking and finding inspiration from colleagues, manufacturers, and distributors at the vanguard of entertainment technology. For more information, visit http://www.ldishow.com/. LDI takes place December 2-8, 2026, in the West Hall of the Las Vegas Convention Center in Las Vegas, NV.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Charlene Soucy
LDI
csoucy@questex.com

Registration Opens for Questex’s LDI 2026, Featuring Early Access to In-Depth LDInstitute™Training

Professionals across live events, entertainment technology, and production can now register for LDI 2026, for the first time, secure seats in sought-after LDInstitute™ courses nearly two months earlier than ever before

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Registration is now open for Live Design International (LDI) 2026, Questex’s must-attend annual event for global entertainment design and technology professionals. Taking place December 2-8, 2026, at the Las Vegas Convention Center, LDI will once again bring together the designers, programmers, engineers, technicians, production teams, manufacturers, and innovators shaping the future of live experiences.

This year’s event is already gearing up to be one of the most exciting in LDI’s history, with expanded professional development opportunities, hundreds of exhibitors, cutting-edge technology demonstrations, immersive experiences, and the industry’s most comprehensive education program.

Early Access to LDInstitute™—A First for LDI

For the first time, attendees can also register early for the highly anticipated LDInstitute™ professional training courses. Many Institute courses feature limited hands-on enrollment and routinely sell out, making early registration the best way to guarantee access to these sought-after training opportunities.

With more than 75 expert-led training courses, many featuring limited hands-on enrollment that sells out each year, early registration gives attendees the best opportunity to secure a seat in some of the industry’s most in-demand technical training.

“LDI is where the live events industry comes together to discover new technology, sharpen skills, and build the relationships that move careers—and our industry—forward,” said Marian Sandberg, Vice President and Brand Leader, LDI. “We’re excited to open registration for LDI 2026 and give attendees early access to our Institute courses. These small-group training experiences provide unparalleled hands-on learning and consistently fill quickly, so we encourage attendees to secure their seats early.”

Register for Industry-Leading LDInstitute™ Training

LDInstitute delivers intensive, hands-on education taught by respected industry professionals across lighting, networking, production technology, media servers, design, and live event systems.

Sessions include:

  • grandMA3 Beginner and grandMA3 Special Topics
  • ETC Eos and High End console Training
  • Setting Up, Testing, and Troubleshooting Lighting Control Systems and Networks
  • Vectorworks Training
  • Green Hippo and Pixera media server Training
  • Ethernet For Entertainment
  • Cutting-edge AI Training
  • Additional technical and professional development courses

The LDInnovation™ Conference Returns

The full LDInnovation™ Conference agenda and speaker lineup will be announced in August, featuring industry leaders, innovators, and practitioners exploring the trends, technologies, and creative ideas shaping the future of live events and entertainment production.

Register Early & Save: Super Early Bird Rates Through August 14

Attendees who register now can take advantage of Super Early Bird pricing through August 14, 2026, and secure the lowest available rates for LDI 2026 and reduced rates for LDInstitute Courses.

LDI 2026 will feature:

  • Hundreds of exhibitors showcasing the latest in lighting, audio, video, projection, staging, automation, rigging, and immersive technologies
  • The LDInnovation™ Conference
  • 75+ LDInstitute™ training courses
  • Live demonstrations
  • Networking events
  • Career development opportunities
  • Experiences celebrating the creativity and technology behind live entertainment

To register to attend LDI, click here. To view LDInstitute Courses, click here.

For sponsorship opportunities, contact Kelly Turner.

Follow LDI on Instagram, LinkedIn, Facebook, X, YouTube and TikTok.

About Live Design International (LDI)
Established in 1988, Live Design International (LDI) is built on a 36-year history as the essential trade show and conference for global live design professionals. Attendees come to LDI to see the latest gear and entertainment technology in action, covering audio, lighting, projection, video, staging, special effects, and XR. It is also a great opportunity to refresh knowledge and professional training, in addition to networking and finding inspiration from colleagues, manufacturers, and distributors at the vanguard of entertainment technology. For more information, visit http://www.ldishow.com/. LDI takes place December 2-8, 2026, in the West Hall of the Las Vegas Convention Center in Las Vegas, NV.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Charlene Soucy
LDI
csoucy@questex.com

Paul Miller to Lead Combined Emerald and Questex Business as Chief Executive Officer

Visionary Events and Media Operator to Drive Organic Growth and Unlock Full Value of New, Scaled, Leading B2B Events Platform

Emerald President and CEO Hervé Sedky to Serve as Senior Advisor Upon Close

 

NEW YORK, June 24, 2026 – The holding company formed to acquire Emerald Holding, Inc. (NYSE: EEX) (“Emerald”) and Questex, LLC (“Questex”) in connection with the previously announced acquisitions by Apollo-managed funds (the “Apollo Funds”) today announced that Paul Miller, current Chief Executive Officer of Questex, will lead the combined company as CEO, effective upon closing of the transaction.

Following the close of the transaction, Hervé Sedky will transition from his current role as President and Chief Executive Officer of Emerald to serve as a senior advisor to the combined company.

Mr. Miller brings over three decades of experience across the events, information services, and media industries and a track record of increasing revenue streams, scaling multi-vertical platforms, and driving growth across cycles. Since becoming CEO of Questex in 2018, he has transformed and expanded the company’s portfolio across industries, including hospitality, travel, healthcare, life sciences, beauty, and technology, achieving remarkable growth in revenue and profit. With deep operational expertise and experience, including successfully integrating acquisitions and expanding innovative customer engagement capabilities powered by first-party data, Mr. Miller is well positioned to bring Emerald and Questex together to drive continued organic growth, pursue strategic acquisitions and realize the full value of the combined business.

“Paul is an experienced operator who shares our vision for building a scaled, customer-centric platform at the forefront of the B2B events industry,” said Shahid Bosan, Managing Director at Apollo. “We are confident in his ability to unite these two organizations to create a distinct platform that is well-positioned for sustained growth and long-term value creation.”

“I am honored to have the opportunity to lead the combined company and work alongside such a talented group of employees across both Emerald and Questex,” said Mr. Miller. “As we embark on this next chapter, my focus will be on bringing together the strengths of both organizations to create a scaled, highly complementary platform that is uniquely positioned to capture the growing demand for trusted, in-person gatherings, leveraging the strength of both companies’ customer relationships and engagement capabilities to continue to deliver value for all our respective stakeholders.”

“Leading Emerald and building a portfolio of market-leading brands alongside an extraordinary team has been one of the defining privileges of my career,” said Mr. Sedky. “This combination creates a stronger platform – one defined by greater scale, deep expertise, expanded capabilities, and a shared commitment to delivering meaningful value for our customers, exhibitors, and partners. I look forward to working with Paul and the rest of the leadership team as we build on that foundation and guide both companies into this next chapter.”

 

Transaction Update
The previously announced transaction is still expected to be completed in the second half of 2026, subject to customary closing conditions and regulatory approvals.

 

About Paul Miller
Paul Miller currently serves as CEO of Questex, where he has shaped the company’s growth strategy and advanced its position as a next-generation information services company across core markets with events at the center and year-round engagement driving deep data to produce better outcomes for customers. Prior to joining Questex in 2018, Mr. Miller served as President of Informa’s Industry & Infrastructure Intelligence where he brought a high level of innovation and creativity to help customers achieve superior ROI on marketing investments. Earlier in his career, he served as President of Penton’s Industry Group and held a variety of leadership positions at UBM, including CEO of UBM Tech, where he led the business’s event expansion into international markets as well as growing digital content and services. Mr. Miller is a Fellow of the Chartered Institute of Marketing.

 

About Apollo
Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of March 31, 2026, Apollo had approximately $1.03 trillion of assets under management. To learn more, please visit www.apollo.com.

 

About Emerald
Emerald Holding, Inc. is a leading U.S.-based B2B event organizer, empowering businesses year-round by expanding meaningful connections, developing influential content, and delivering powerful commerce-driven solutions. As the owner and operator of a curated portfolio of B2B events spanning trade shows, conferences, B2C showcases and a scaled Executive Peer Network platform. Emerald also delivers dynamic solutions across leading industries through its robust content and e-commerce marketplace. Emerald is a trusted partner for its thousands of customers, predominantly small and medium-sized businesses, playing a pivotal role in driving ongoing commerce through streamlined buying, selling, and networking opportunities. Powered by an experienced, talented and deeply engaged team, Emerald is fostering impactful engagement and delivering unparalleled market access with a commitment to driving business growth 365 days a year. For more: https://www.emeraldx.com.

 

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

 

Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking information may be identified by such terms as “believes”, “expects”, “will”, “may”, and other similar expressions. In particular, the forward-looking information contained in this press release includes statements regarding the proposed transaction described herein, including the proposed timing and steps contemplated in respect of the proposed transaction and approvals with respect thereto. These statements are based on the current expectations as of the date hereof, and although they are believed to be reasonable, they are inherently uncertain and not guaranteed. These statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and other factors outside of Emerald’s control that may cause its business, industry, strategy, financing activities and the ability of the parties to complete the proposed transaction to differ materially. See “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Emerald’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings for a discussion of factors that may affect Emerald’s business performance. Emerald undertakes no obligation to update or revise any of the forward-looking statements contained herein, whether as a result of new information, future events or otherwise.

 

Contacts

Noah Gunn
Global Head of Investor Relations
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
(212) 822-0491
Communications@apollo.com

Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda

Conference set to take place October 29-30 in Boston

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) — Questex’s Fierce Life Sciences today announces the agenda for the PODD: Partnership Opportunities in Drug Delivery Conference, the premier gathering for drug delivery industry leaders. Set to take place October 29-30, 2026, at the Sheraton Boston Hotel, the 16th annual PODD conference brings together over 1,000 executives, innovators and strategic decision-makers to advance the design and development of drug delivery systems and devices to improve patient lives.

“As someone working at the forefront of emerging modalities, I see PODD as uniquely valuable because it brings together the full ecosystem needed to translate novel biology into viable therapies, where delivery often becomes the gating factor,” said Suman Luthra, Director, Discovery Pharmaceutical Sciences, Merck.

With more than 150 sessions across multiple tracks, the PODD conference features keynotes, panels, roundtables and case studies with thought leaders from across the pharma and drug delivery ecosystem.

2026 featured sessions include:

  • Keynote: Dr George Yancopoulos, Regeneron’s Co-Founder, Board Co-Chair, President and Chief Scientific Officer will join MIT’s Dr Robert Langer, a pioneer in the research and development of drug delivery technology, to discuss the state of innovation in the drug delivery industry.
  • Patient Keynote: Sabrena Gates will share her family’s journey with Luxturna, a gene therapy designed to treat inherited retinal diseases caused by mutations in both copies of the RPE65 gene.
  • How Companies Use AI to Support Drug Delivery will be addressed by AstraZeneca’s Head of Advanced Drug Delivery, Dr Annette Bak, Intrepid Lab’s Co-Founder & CEO, Dr Christine Allen, GSK’s VP, Portfolio and Technology Development, Dr Manish Gupta, Eli Lilly and Company’s VP, Drug Delivery, Device, Connected Solutions & Innovation, Dr Anand Subramony, and Bristol Myers Squibb’s Director, Portfolio Strategy & Integration, Rashmi Thakur.
  • Johnson & Johnson’s Scientific Director, Oral Peptide Formulation Technologies, Wouter Müllers, Vertex Pharmaceutical’s VP, Combination Devices, David Dunleavy, Daiichi Sankyo’s VP, Global Search & Evaluation – Early Stage, Global Business Development, Dr Shiv Krishnan, and Astellas Pharma’s, Senior Director, Head of DDS, Dr Takayuki Yoshida will present on their companies’ partnering philosophy, current needs and scouting interests, as related to drug delivery and enabling technologies as part of the Pharma Company Spotlights.
  • The Successful Partnering between Pharma, Drug Delivery and Academia panel is led by Boehringer Ingelheim’s Senior Associate Director, Innovation Technology, Dr Jill Steinbach-Rankins, with Johnson & Johnson Innovative Medicines’ Senior Director External Innovation DPDS, Dr Elena Diez Cecilia, MIT’s Director, Strategic Alliances & Partnerships, Dr Tarek Fadel, and CSL Bering’s Search & Evaluation, Immunoglobulin (Ig) Therapeutic Area and Technologies Lead Dr Sarah Tao.
  • Sun Pharmaceutical’s Mark Simon, UnitedHealth Group’s, Lambert van der and Sherman Healthcare Solutions’ Dr Michael Sherman lead the Payer discussion on how companies can position their drug delivery-enabled therapies for reimbursement, the impact of direct-to-consumer accessibility on GLP-1 drugs, and cell and gene therapies for non-malignancies and conditions for which there are already effective treatments.

The PODD conference will also feature multi-stakeholder participation, including leaders from AbbVie, Alexion, Alnylam Pharmaceuticals, Astellas Pharma, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi USA, CSL Bering, Daiichi Sankyo, Eli Lilly & Company, Genentech, Gilead Sciences, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Sun Pharma, Takeda Pharmaceuticals, Teva Pharmaceuticals, Upstream Bio, Vertex Pharmaceuticals and more.

The 2026 Drug Delivery Technology Presentations cover:

  • Injectable Formulations & Technologies
  • Oral, Nasal, Pulmonary & Other Non-Injectable Technologies
  • Novel Injectable & Non-Injectable Technologies
  • Novel Devices, Self-Injectables, Wearables & Connected Devices
  • Novel Device Technologies
  • Cell, Gene, & Novel Biologics Delivery
  • Novel Materials & Excipient Innovation
  • Self-Injection Devices, Syringes, Primary Container & Packaging Solutions

To register to attend PODD, click here.

Learn more about sponsorship opportunities, here.

About PODD: Partnership Opportunities in Drug Delivery Conference

Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals, and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.

To learn more about the PODD conference, please visit PODDConference.com.

About Fierce Life Sciences

Fierce Life Sciences Events offers a full suite of news, analysis and event education, all in one place. From preclinical research to market and beyond, our team of editors and handpicked experts deliver insights you can source with confidence and events, both virtual and live, that support professional and business growth.

About Questex

Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact

Allyson Adams

PODD

aadams@questex.com 

Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda

Conference set to take place October 29-30 in Boston

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) — Questex’s Fierce Life Sciences today announces the agenda for the PODD: Partnership Opportunities in Drug Delivery Conference, the premier gathering for drug delivery industry leaders. Set to take place October 29-30, 2026, at the Sheraton Boston Hotel, the 16th annual PODD conference brings together over 1,000 executives, innovators and strategic decision-makers to advance the design and development of drug delivery systems and devices to improve patient lives.

“As someone working at the forefront of emerging modalities, I see PODD as uniquely valuable because it brings together the full ecosystem needed to translate novel biology into viable therapies, where delivery often becomes the gating factor,” said Suman Luthra, Director, Discovery Pharmaceutical Sciences, Merck.

With more than 150 sessions across multiple tracks, the PODD conference features keynotes, panels, roundtables and case studies with thought leaders from across the pharma and drug delivery ecosystem.

2026 featured sessions include:

  • Keynote: Dr George Yancopoulos, Regeneron’s Co-Founder, Board Co-Chair, President and Chief Scientific Officer will join MIT’s Dr Robert Langer, a pioneer in the research and development of drug delivery technology, to discuss the state of innovation in the drug delivery industry.
  • Patient Keynote: Sabrena Gates will share her family’s journey with Luxturna, a gene therapy designed to treat inherited retinal diseases caused by mutations in both copies of the RPE65 gene.
  • How Companies Use AI to Support Drug Delivery will be addressed by AstraZeneca’s Head of Advanced Drug Delivery, Dr Annette Bak, Intrepid Lab’s Co-Founder & CEO, Dr Christine Allen, GSK’s VP, Portfolio and Technology Development, Dr Manish Gupta, Eli Lilly and Company’s VP, Drug Delivery, Device, Connected Solutions & Innovation, Dr Anand Subramony, and Bristol Myers Squibb’s Director, Portfolio Strategy & Integration, Rashmi Thakur.
  • Johnson & Johnson’s Scientific Director, Oral Peptide Formulation Technologies, Wouter Müllers, Vertex Pharmaceutical’s VP, Combination Devices, David Dunleavy, Daiichi Sankyo’s VP, Global Search & Evaluation – Early Stage, Global Business Development, Dr Shiv Krishnan, and Astellas Pharma’s, Senior Director, Head of DDS, Dr Takayuki Yoshida will present on their companies’ partnering philosophy, current needs and scouting interests, as related to drug delivery and enabling technologies as part of the Pharma Company Spotlights.
  • The Successful Partnering between Pharma, Drug Delivery and Academia panel is led by Boehringer Ingelheim’s Senior Associate Director, Innovation Technology, Dr Jill Steinbach-Rankins, with Johnson & Johnson Innovative Medicines’ Senior Director External Innovation DPDS, Dr Elena Diez Cecilia, MIT’s Director, Strategic Alliances & Partnerships, Dr Tarek Fadel, and CSL Bering’s Search & Evaluation, Immunoglobulin (Ig) Therapeutic Area and Technologies Lead Dr Sarah Tao.
  • Sun Pharmaceutical’s Mark Simon, UnitedHealth Group’s, Lambert van der and Sherman Healthcare Solutions’ Dr Michael Sherman lead the Payer discussion on how companies can position their drug delivery-enabled therapies for reimbursement, the impact of direct-to-consumer accessibility on GLP-1 drugs, and cell and gene therapies for non-malignancies and conditions for which there are already effective treatments.

The PODD conference will also feature multi-stakeholder participation, including leaders from AbbVie, Alexion, Alnylam Pharmaceuticals, Astellas Pharma, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi USA, CSL Bering, Daiichi Sankyo, Eli Lilly & Company, Genentech, Gilead Sciences, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Sun Pharma, Takeda Pharmaceuticals, Teva Pharmaceuticals, Upstream Bio, Vertex Pharmaceuticals and more.

The 2026 Drug Delivery Technology Presentations cover:

  • Injectable Formulations & Technologies
  • Oral, Nasal, Pulmonary & Other Non-Injectable Technologies
  • Novel Injectable & Non-Injectable Technologies
  • Novel Devices, Self-Injectables, Wearables & Connected Devices
  • Novel Device Technologies
  • Cell, Gene, & Novel Biologics Delivery
  • Novel Materials & Excipient Innovation
  • Self-Injection Devices, Syringes, Primary Container & Packaging Solutions

To register to attend PODD, click here.

Learn more about sponsorship opportunities, here.

About PODD: Partnership Opportunities in Drug Delivery Conference

Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals, and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.

To learn more about the PODD conference, please visit PODDConference.com.

About Fierce Life Sciences

Fierce Life Sciences Events offers a full suite of news, analysis and event education, all in one place. From preclinical research to market and beyond, our team of editors and handpicked experts deliver insights you can source with confidence and events, both virtual and live, that support professional and business growth.

About Questex

Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact

Allyson Adams

PODD

aadams@questex.com 

Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) — DPHARM, the leading innovation event for clinical trial operation executives, announces the 16th annual conference agenda including its senior leadership and keynotes. DPHARM which is now part of Questex’s Fierce Life Sciences, takes place September 15-16, 2026, at the Sheraton Boston Hotel.

The first line up of senior level clinical operation executives include:

  • Jennifer Sheller, SVP, Head of Global Clinical Trial Operations, Global Clinical Development, Merck
  • David Carruthers, VP, Head of Global Clinical Operations, BioPharmaceuticals R&D, AstraZeneca
  • Nikki Amaratunge, VP, Clinical Development Operations, Head of Clinical Site Management, AbbVie
  • Karen Correa, VP, Clinical Development Operations, Boehringer Ingelheim
  • Bari Kowal, SVP, Head Development Operations & Portfolio Management, Regeneron

The 2026 Keynotes include:

John Volanthen, world-renowned British cave diver who was integral in the rescue of the Thai Boys’ soccer team in 2018 gives the disruptive keynote.

Gunnar Esiason, Cystic Fibrosis Patient Advocate and industry executive shares his three-decade patient journey.

Janelle A. Sabo, SVP of Clinical Research Capabilities, Eli Lilly and Company, presents the Industry Keynote on the most innovative trends shaping the future of clinical research.

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, speaks on change management, why innovation adoption stalls and how to overcome it.

Jeremy Walsh, Former Chief AI Officer, US Food and Drug Administration, speaks on real-time clinical trials.

Core themes of the agenda include real-time clinical trials, scalable innovation, workforce development, enterprise-wide AI adoption, and the redesign of clinical operating models to support faster, more efficient development.

Other presenting pharmaceutical companies include Abeona Therapeutics, Acelot Inc., Alexion, Alnylam Pharmaceuticals, Amgen, AskBio, Astellas, AstraZeneca, Bayer, BeOne Medicines, Biogen, BMS, CSL, Daiichi Sankyo, Eli Lilly, Genmab, Gilead Sciences, GSK, J&J Innovative Medicine, Jazz Pharmaceuticals, Kyowa Kirin, Novartis, Novo Nordisk, Parabilis Medicines, Pfizer, Sanofi, Takeda, Teva Pharmaceuticals, and Vertex Pharmaceuticals.

“DPHARM 2026 will showcase the latest innovative approaches and practical strategies to scale what works, from AI to operating models, to drive measurable improvements in trial performance and patient experience.” said Tracey Kimball, DPHARM Conference Director.

In addition to the keynotes, DPHARM 2026 has over 200 speakers. The DPHARM agenda is carefully curated with the guidance of more than 70 advisors representing pharmaceutical senior clinical operation executives, patient advocacy, clinical sites, innovative tech and service companies, academia and regulatory authorities.

DPHARM will be preceded by the Partnerships with Sites Summit, September 14, 2026. To learn more, visit www.partnershipswithsites.com/

For the full DPHARM agenda, visit www.DPHARMconference.com.

About DPHARM:
DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders report on innovations that are modernizing clinical trials and reducing patient burden. The concept of DPHARM was founded by Pfizer and Johnson & Johnson, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM takes place September 15-16 at the Sheraton Boston Hotel in Boston, MA.

About Questex:
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Allyson Adams
DPHARM
aadams@questex.com         

Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) — DPHARM, the leading innovation event for clinical trial operation executives, announces the 16th annual conference agenda including its senior leadership and keynotes. DPHARM which is now part of Questex’s Fierce Life Sciences, takes place September 15-16, 2026, at the Sheraton Boston Hotel.

The first line up of senior level clinical operation executives include:

  • Jennifer Sheller, SVP, Head of Global Clinical Trial Operations, Global Clinical Development, Merck
  • David Carruthers, VP, Head of Global Clinical Operations, BioPharmaceuticals R&D, AstraZeneca
  • Nikki Amaratunge, VP, Clinical Development Operations, Head of Clinical Site Management, AbbVie
  • Karen Correa, VP, Clinical Development Operations, Boehringer Ingelheim
  • Bari Kowal, SVP, Head Development Operations & Portfolio Management, Regeneron

The 2026 Keynotes include:

John Volanthen, world-renowned British cave diver who was integral in the rescue of the Thai Boys’ soccer team in 2018 gives the disruptive keynote.

Gunnar Esiason, Cystic Fibrosis Patient Advocate and industry executive shares his three-decade patient journey.

Janelle A. Sabo, SVP of Clinical Research Capabilities, Eli Lilly and Company, presents the Industry Keynote on the most innovative trends shaping the future of clinical research.

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, speaks on change management, why innovation adoption stalls and how to overcome it.

Jeremy Walsh, Former Chief AI Officer, US Food and Drug Administration, speaks on real-time clinical trials.

Core themes of the agenda include real-time clinical trials, scalable innovation, workforce development, enterprise-wide AI adoption, and the redesign of clinical operating models to support faster, more efficient development.

Other presenting pharmaceutical companies include Abeona Therapeutics, Acelot Inc., Alexion, Alnylam Pharmaceuticals, Amgen, AskBio, Astellas, AstraZeneca, Bayer, BeOne Medicines, Biogen, BMS, CSL, Daiichi Sankyo, Eli Lilly, Genmab, Gilead Sciences, GSK, J&J Innovative Medicine, Jazz Pharmaceuticals, Kyowa Kirin, Novartis, Novo Nordisk, Parabilis Medicines, Pfizer, Sanofi, Takeda, Teva Pharmaceuticals, and Vertex Pharmaceuticals.

“DPHARM 2026 will showcase the latest innovative approaches and practical strategies to scale what works, from AI to operating models, to drive measurable improvements in trial performance and patient experience.” said Tracey Kimball, DPHARM Conference Director.

In addition to the keynotes, DPHARM 2026 has over 200 speakers. The DPHARM agenda is carefully curated with the guidance of more than 70 advisors representing pharmaceutical senior clinical operation executives, patient advocacy, clinical sites, innovative tech and service companies, academia and regulatory authorities.

DPHARM will be preceded by the Partnerships with Sites Summit, September 14, 2026. To learn more, visit www.partnershipswithsites.com/

For the full DPHARM agenda, visit www.DPHARMconference.com.

About DPHARM:
DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders report on innovations that are modernizing clinical trials and reducing patient burden. The concept of DPHARM was founded by Pfizer and Johnson & Johnson, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM takes place September 15-16 at the Sheraton Boston Hotel in Boston, MA.

About Questex:
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Allyson Adams
DPHARM
aadams@questex.com         

The 48th Annual NYU International Hospitality Investment Forum Attracted Over 700 Investors Representing $723B in Hotel Assets Under Management to Drive Deal-Making

NYU IHIF 2027 Takes Place June 6-8 at the Marriott Marquis in New York

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) — Earlier this month at the 48th annual NYU International Hospitality Investment Forum (NYU IHIF), operated by Questex, a leading information services and event company, in partnership with the NYU School of Professional Studies (NYU SPS) and its Jonathan M. Tisch Center of Hospitality, top industry executives, from CEOs of hotel brands to various investment and real estate executives, discussed the latest trends, economic influences and projections. NYU IHIF hosted more than 2,500 attendees, 28% of which were equity investors, representing more than $723B in hotel assets under management. Thirty-three percent of investor attendees attended the conference for the first time, demonstrating the increasing appeal of hospitality as an investment class. 

The annual conference agenda delivered unparalleled thought leadership through keynotes, general sessions, workshops and networking events. Nearly 150 industry executives delivered unparalleled thought leadership through panels, fireside chats, case study presentations and roundtable discussions.

With the theme “Sharpening the Edge,” NYU IHIF brought the industry together to examine the forces shaping the market with curated tracks and deep content for three days of networking, insights and deal-making.

The opening keynote address was delivered by Anthony Scaramucci, Founder and Managing Partner, SkyBridge and Founder and Chairman, SALT. His address “Unbreakable Resilience: An Insider’s Perspective on Power, Communications and Business” provided an insider’s view into how geopolitical forces and societal dynamics are shaping today’s U.S. markets. He also explored what resilience truly means for leaders and businesses navigating volatility and uncertainty. 

The Global Hospitality CEO Panel: “The View from the Boardroom” focused on market dynamics, emerging trends and strategies for adapting to uncertainty. The leaders of the world’s major hospitality companies – Christopher J. Nassetta, President and CEO, Hilton Worldwide; Mark Hoplamazian, President and CEO, Hyatt; Geoff Ballotti, President and CEO, Wyndham Hotels and Resorts; Elie Maalouf, CEO, IHG Hotels and Resorts; and Sebastien Bazin, Chairman and CEO, Accor shared insights. The session was moderated by Sara Eisen, Anchor, CNBC.

Danny Meyer, Founder and Executive Chairman, Union Square Hospitality Group (USHG) received the Jonathan Tisch Active Citizenship Award, which celebrates the positive impact and achievements of a leader in the hospitality industry. Meyer also participated in a Fireside Chat with Tisch, covering the state of the industry and his philanthropy.

Additionally, the Hilton Cleveland Downtown, CHMWarnick received the HAMA U.S. Asset Management Achievement Award. 

Other prominent leaders presented at NYU IHIF:

  • David Pepper, Chief Development Officer, Choice Hotels
  • Satya Anand, Group President U.S., Canada and Latin America, Marriott International
  • Claire Wallace, SVP Acquisitions and Development, Pyramid Global Hospitality
  • Omer Acar, CEO Raffles and Fairmont, Accor
  • Jonathan Halkyard, Chief Financial Officer, MGM Resorts International
  • Tim Abram, Managing Director and Global Co Head of Hotels, Starwood Capital Group
  • Ben Brunt, Managing Principal and Chief Investment Officer, Noble Investment Group
  • Scott Ellman, Managing Director, Eastdil Secured
  • Michael Mohapp, Partner, KSL Capital Partners
  • Steen Petri, Managing Director Investments, HEI Hotels and Resorts
  • Tiffany Cooper, Head of Development Americas, Mandarin Oriental
  • Andrea Grigg, Global Head of Hotel Asset Management, CBRE Hotels

Additionally, NYU IHIF hosted the second edition of BxR – Brand x Residential, which was dedicated entirely to investment, development and strategy within branded residences.

NYU IHIF attendees had the opportunity to meet with over 70 leading companies such as Accor, Hilton, Marriott International, IHG Hotels & Resorts, Visit Portugal, BWH Hotels, MEWS and Booking.com introducing the latest ventures, investments and innovations redefining guest experiences, operational efficiency and deal structures.

Select industry announcements made around IHIF EMEA:

  • Hilton announced the launch of a new brand, Undergraduate by Hilton, an upper-midscale product developed to serve a broader range of college and university markets. [Read the news here.]
  • CoStar and Tourism Economics upgrade their U.S. hotel performance outlook and now anticipates RevPAR will increase 2.8% year over year for full-year 2026. [Read the news here.]
  • MGM Resorts International confirms receipt of acquisition proposal from People Incorporated. [Read the news here.]

“The NYU International Hospitality Investment Forum offered insights from leaders actively deploying capital and operating assets in today’s market. It was the place to be for those looking to stay sharp and close deals. Every moment of the conference was designed to move the conversations forward, whether it was on stages, in meeting rooms or during receptions,” said Alexi Khajavi, Group President, Living & Hospitality, Questex.

“NYU IHIF is where the most influential voices in hospitality converge. It’s where investors and decision-makers have real conversations, gain access to market-moving insights and build relationships. It’s where the industry set its agenda for the year ahead,” added Nicolas Graf, Associate Dean of the Jonathan M. Tisch Center of Hospitality.

A share of proceeds from the event will help fund student scholarships at the NYU SPS Jonathan M. Tisch Center of Hospitality and further support the program’s mission of educating and preparing future leaders and innovators for careers in global hospitality management, travel, and tourism.

Upcoming International Hospitality Investment Forums
IHIF Asia will take place in September 16-18, 2026 in Hong Kong. Register to attend here. For sponsorship opportunities, contact Andrew Walmsley at awalmsley@questex.com.

IHIF EMEA will take place May 10-12, 2027 in Germany. Click here for sponsorship opportunities.

NYU IHIF 2027 takes place June 6-8 at the Marriott Marquis in New York. For sponsorship opportunities, contact Robert Britt at rbritt@questex.com.

Stay connected with the NYU IHIF on LinkedIn, Instagram and X.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

About the NYU SPS Jonathan M. Tisch Center of Hospitality
The NYU SPS Jonathan M. Tisch Center of Hospitality, now celebrating nearly 30 years of academic excellence, is a leading center for the study of hospitality, travel, and tourism. Founded in 1995, the Tisch Center was established in response to the growing need for hospitality and tourism undergraduate and graduate education. Its cutting-edge curricula attract bright, motivated students who seek to become leaders in their fields. The Tisch Center recently launched the Hospitality Innovation Hub (HI Hub), which will foster entrepreneurship and creative solutions for the industries it serves. For more information, visit sps.nyu.edu/tisch.

Media Contacts
Ahna Holloran
NYU IHIF
aholloran@questex.com

Meryl Franzman
NYU IHIF
mfranzman@questex.com

The 48th Annual NYU International Hospitality Investment Forum Attracted Over 700 Investors Representing $723B in Hotel Assets Under Management to Drive Deal-Making

NYU IHIF 2027 Takes Place June 6-8 at the Marriott Marquis in New York

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) — Earlier this month at the 48th annual NYU International Hospitality Investment Forum (NYU IHIF), operated by Questex, a leading information services and event company, in partnership with the NYU School of Professional Studies (NYU SPS) and its Jonathan M. Tisch Center of Hospitality, top industry executives, from CEOs of hotel brands to various investment and real estate executives, discussed the latest trends, economic influences and projections. NYU IHIF hosted more than 2,500 attendees, 28% of which were equity investors, representing more than $723B in hotel assets under management. Thirty-three percent of investor attendees attended the conference for the first time, demonstrating the increasing appeal of hospitality as an investment class. 

The annual conference agenda delivered unparalleled thought leadership through keynotes, general sessions, workshops and networking events. Nearly 150 industry executives delivered unparalleled thought leadership through panels, fireside chats, case study presentations and roundtable discussions.

With the theme “Sharpening the Edge,” NYU IHIF brought the industry together to examine the forces shaping the market with curated tracks and deep content for three days of networking, insights and deal-making.

The opening keynote address was delivered by Anthony Scaramucci, Founder and Managing Partner, SkyBridge and Founder and Chairman, SALT. His address “Unbreakable Resilience: An Insider’s Perspective on Power, Communications and Business” provided an insider’s view into how geopolitical forces and societal dynamics are shaping today’s U.S. markets. He also explored what resilience truly means for leaders and businesses navigating volatility and uncertainty. 

The Global Hospitality CEO Panel: “The View from the Boardroom” focused on market dynamics, emerging trends and strategies for adapting to uncertainty. The leaders of the world’s major hospitality companies – Christopher J. Nassetta, President and CEO, Hilton Worldwide; Mark Hoplamazian, President and CEO, Hyatt; Geoff Ballotti, President and CEO, Wyndham Hotels and Resorts; Elie Maalouf, CEO, IHG Hotels and Resorts; and Sebastien Bazin, Chairman and CEO, Accor shared insights. The session was moderated by Sara Eisen, Anchor, CNBC.

Danny Meyer, Founder and Executive Chairman, Union Square Hospitality Group (USHG) received the Jonathan Tisch Active Citizenship Award, which celebrates the positive impact and achievements of a leader in the hospitality industry. Meyer also participated in a Fireside Chat with Tisch, covering the state of the industry and his philanthropy.

Additionally, the Hilton Cleveland Downtown, CHMWarnick received the HAMA U.S. Asset Management Achievement Award. 

Other prominent leaders presented at NYU IHIF:

  • David Pepper, Chief Development Officer, Choice Hotels
  • Satya Anand, Group President U.S., Canada and Latin America, Marriott International
  • Claire Wallace, SVP Acquisitions and Development, Pyramid Global Hospitality
  • Omer Acar, CEO Raffles and Fairmont, Accor
  • Jonathan Halkyard, Chief Financial Officer, MGM Resorts International
  • Tim Abram, Managing Director and Global Co Head of Hotels, Starwood Capital Group
  • Ben Brunt, Managing Principal and Chief Investment Officer, Noble Investment Group
  • Scott Ellman, Managing Director, Eastdil Secured
  • Michael Mohapp, Partner, KSL Capital Partners
  • Steen Petri, Managing Director Investments, HEI Hotels and Resorts
  • Tiffany Cooper, Head of Development Americas, Mandarin Oriental
  • Andrea Grigg, Global Head of Hotel Asset Management, CBRE Hotels

Additionally, NYU IHIF hosted the second edition of BxR – Brand x Residential, which was dedicated entirely to investment, development and strategy within branded residences.

NYU IHIF attendees had the opportunity to meet with over 70 leading companies such as Accor, Hilton, Marriott International, IHG Hotels & Resorts, Visit Portugal, BWH Hotels, MEWS and Booking.com introducing the latest ventures, investments and innovations redefining guest experiences, operational efficiency and deal structures.

Select industry announcements made around IHIF EMEA:

  • Hilton announced the launch of a new brand, Undergraduate by Hilton, an upper-midscale product developed to serve a broader range of college and university markets. [Read the news here.]
  • CoStar and Tourism Economics upgrade their U.S. hotel performance outlook and now anticipates RevPAR will increase 2.8% year over year for full-year 2026. [Read the news here.]
  • MGM Resorts International confirms receipt of acquisition proposal from People Incorporated. [Read the news here.]

“The NYU International Hospitality Investment Forum offered insights from leaders actively deploying capital and operating assets in today’s market. It was the place to be for those looking to stay sharp and close deals. Every moment of the conference was designed to move the conversations forward, whether it was on stages, in meeting rooms or during receptions,” said Alexi Khajavi, Group President, Living & Hospitality, Questex.

“NYU IHIF is where the most influential voices in hospitality converge. It’s where investors and decision-makers have real conversations, gain access to market-moving insights and build relationships. It’s where the industry set its agenda for the year ahead,” added Nicolas Graf, Associate Dean of the Jonathan M. Tisch Center of Hospitality.

A share of proceeds from the event will help fund student scholarships at the NYU SPS Jonathan M. Tisch Center of Hospitality and further support the program’s mission of educating and preparing future leaders and innovators for careers in global hospitality management, travel, and tourism.

Upcoming International Hospitality Investment Forums
IHIF Asia will take place in September 16-18, 2026 in Hong Kong. Register to attend here. For sponsorship opportunities, contact Andrew Walmsley at awalmsley@questex.com.

IHIF EMEA will take place May 10-12, 2027 in Germany. Click here for sponsorship opportunities.

NYU IHIF 2027 takes place June 6-8 at the Marriott Marquis in New York. For sponsorship opportunities, contact Robert Britt at rbritt@questex.com.

Stay connected with the NYU IHIF on LinkedIn, Instagram and X.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

About the NYU SPS Jonathan M. Tisch Center of Hospitality
The NYU SPS Jonathan M. Tisch Center of Hospitality, now celebrating nearly 30 years of academic excellence, is a leading center for the study of hospitality, travel, and tourism. Founded in 1995, the Tisch Center was established in response to the growing need for hospitality and tourism undergraduate and graduate education. Its cutting-edge curricula attract bright, motivated students who seek to become leaders in their fields. The Tisch Center recently launched the Hospitality Innovation Hub (HI Hub), which will foster entrepreneurship and creative solutions for the industries it serves. For more information, visit sps.nyu.edu/tisch.

Media Contacts
Ahna Holloran
NYU IHIF
aholloran@questex.com

Meryl Franzman
NYU IHIF
mfranzman@questex.com

Questex’s StreamTV Show Announces the 2026 StreamTV Awards Winners

DENVER, June 18, 2026 (GLOBE NEWSWIRE) — Questex’s StreamTV Show, the streaming industry’s fastest-growing event, today announces the winners of the 2026 StreamTV Awards – the ultimate celebration of the visionaries and trailblazers transforming the streaming industry. StreamTV Show takes place June 16-19 in Denver, Colorado.

Kevin Gray, Founder of StreamTV Show and VP, Questex said, “This year’s competition reached a new level of excitement, with winners earning recognition for breakthrough innovation, exceptional audience engagement, strategic vision, impressive revenue growth and transformative partnerships. Congratulations to the leaders and companies driving the next chapter of the streaming industry.”

The StreamTV Awards Winners

  • Advertising Executive of the Year: Lauren Benedict, VP, Global Ad Sales and Partnerships, Roku
  • Content Partnerships Executive of the Year – Acquisition: Anthony Layser, Executive Director, Content Acquisitions & Programming Strategy, Xumo
  • Content Partnerships Executive of the Year – Distribution: Stefan Van Engen, VP, Content Partnership, Acquisition, Distribution & Experience, Xumo
  • Emerging Leaders Class of 2026:
    • Chelsea Duong, Xumo
    • Elizabeth Lehrer, Pluto TV
    • Eric Steigelfest, PurePlay AI
    • Felipe Saltz, NBA
    • Kate Dery, AMC Global Media
    • Lady Learned, Xumo
    • Mike Gould, Cineflix Rights
    • Murphy VandeMotter, Madhive
  • FAST Channel of the Year: F1 channel by C15 Studio
  • Innovation in Advertising: Club Canela by Canela Media
  • Innovation in Content Delivery & Distribution: MKIO Multiview with Comcast’s “Create your own Multiview” by Mediakind & Comcast
  • Innovation in Monetization: The Digital Vending Machine® from Bango
  • Innovation in User Experience: The Chosen App Experience from Come and See Foundation by Robosoft Technologies
  • Marketing Campaign of the Year: “The Holidays Are Brutal” by Pluto TV
  • StreamTV Impact Award: Roku
  • Streaming Platform of the Year: Roku
  • Technology Executive of the Year:  Alex Groysman, VP of Ad Product Development, Spectrum Reach
  • Trailblazer Award: Vince Torres, Chief Marketing Officer, DIRECTV

Where the Streaming Industry Comes Together
StreamTV Show 2026 will bring together thousands of executives across streaming, advertising, sports, content, platforms, and technology for four days of strategy, networking, and business-driving conversations shaping the future of media. StreamTV Show takes place June 16-19 in Denver, Colorado.

Attendee Registration: Register here.
Press registration: Available here.
Interested in sponsoring or exhibiting? Contact our sales team.

Stay in the loop: Connect with us on LinkedIn, Facebook, X, Instagram and YouTube.

About The StreamTV Show
StreamTV Show isn’t just a market and expo – it’s a community! From insightful sessions to lively networking events, this is where deals get made, partnerships are forged, and the future of streaming is shaped.

Produced and managed by Questex, StreamTV is widely known as the streaming industry’s largest annual event. For more information, visit http://www.streamtvshow.com. The StreamTV Show is supported by the event’s official publication, StreamTV Insider, the streaming TV industry’s daily monitor. For more information, visit https://www.streamtvinsider.com.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Charlene Soucy
StreamTV Show
csoucy@questex.com